# Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer

> **NCT07516626** · — · NOT_YET_RECRUITING · sponsor: **Atlas University** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer
- Locally Advanced Breast Cancer (LABC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07516626
- **Lead sponsor:** Atlas University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-06
- **Final completion:** 2029-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516626, "Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07516626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*